Skip to search formSkip to main contentSkip to account menu

NK 121

Known as: NK-121, NK121 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
The interaction of cis-1,1-cyclobutanedicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) (NK121) and cis-diammine… 
1994
1994
[SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butane-diamine-N,N')platinum (CI-973) is a cisplatin analogue that… 
1993
1993
Cisplatin continues to be one of the most commonly used cytotoxic agent. Problems of drug resistance and nephrotoxicity have… 
1993
1993
New platinum derivatives were synthesized to overcome problems of cisplatin resistance and nephrotoxicity. Five platinum… 
Review
1993
Review
1993
New cisplatinum derivatives of 254-S, DWA2114R and NK121 developed in Japan were reviewed. These three compounds have less… 
1992
1992
To determine the optimal administration schedules of the newly synthesized, less nephrotoxic platinum analog NK121 and less… 
1991
1991
Development of CDDP analogues in Japan has been concerned with second generation analogues, especially which need no hydration or… 
1991
1991
The closed relationship between nasopharyngeal carcinoma (NPC) and Epstein-Barr virus (EBV) has been pointed out. However, it…